Cite
HARVARD Citation
Stilgenbauer, S. et al. (n.d.). Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Lancet oncology. 17 (6), pp. 768-778. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stilgenbauer, S. et al. (n.d.). Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Lancet oncology. 17 (6), pp. 768-778. [Online].